SABCS 2005
2 interviews
San Antonio Breast Cancer Symposium
Interviews and expert commentary from SABCS 2005 — study authors and key opinion leaders discuss the findings and their clinical implications.
Audio Journal of Oncology 14.1, February 2006
Reporting from: San Antonio Breast Cancer Symposium 2005 Scientific Editors: George Canellos, Dana-Farber Cancer Institute, Boston Gordon McVie, European Institute of Oncology, Milan Pat Price, Christ
9 January 2006
Non-Anthracyline Regimen May Be O.K. for Patients with Early Breast Cancer taking Trastuzumab (Herceptin)
Dennis Slamon, UCLA School of Medicine, Los Angeles It may be reasonable to replace the anthracycline component of adjuvant chemotherapy with carboplatin in HER-2 positive patients with early breast c
11 December 2005